For HCHE it is important to encourage the exchange with international researchers. For this purpose, we accept guest scientists at HCHE on the one hand, and support our members in educating themselves further abroad on the other.
Here you can find reports about HCHE members abroad:
Research stay of Dr. Ricarda Milstein at the Department of Health Policy of the LSE
From October to December 2021, Ricarda Milstein was a visiting fellow at the Department of Health Policy at the London School of Economics and Political Science with Professor Elias Mossialos. On site, she examined reforms to the hospital reimbursement system and exchanged ideas with researchers from the LSE, as well as think tanks and the NHS.
The Department of Health Policy is one of the world's leading health policy institutes and is known for its excellent research and high practical relevance.
"Thanks to the research stay, I was able to experience the new, comprehensive reforms of the reimbursement system up close and make valuable contacts. These insights can offer a useful contribution to the German healthcare system."
Research stay of the HCHE Young Researcher Award winner
Shushanik Margaryan won the first HCHE Young Researcher Award in June 2021. The award was endowed with a research stay. From September to October 2021, Shushanik Margaryan was a guest at the Institute for Health and Society at the University of Oslo.
She was hosted by Prof. Tor Iversen in the Department of Health Management and Health Economics. The department has a strong multidisciplinary research activity involving economists, political scientists and medical doctors.
"My research stay at the University of Oslo has been very fruitful so far. Not only have I had the opportunity to present my current research here at the department, but I have also benefited from exciting discussions with members of the department. I have gained valuable insights into the Norwegian health system and how close the collaboration between policy and research can be here."
Cost-effectiveness analysis for U.S. stroke patients.
From July 2021, HCHE member Louisa-Kristin Muntendorf worked on a cost-effectiveness analysis for U.S. stroke patients with unknown onset dates. Due to current travel restrictions, the work was conducted online and then presented at a cross-faculty colloquium at Harvard University in Fall 2021.
The European, multicenter WAKE-UP study led by the Universitätsklinikum Hamburg-Eppendorf has shown for the first time that even patients who suffer a stroke while sleeping and only notice the symptoms after waking up the next morning can benefit from so-called thrombolysis.
Together with Prof. Ankur Pandya (Harvard T.C. Chan School of Public Health), she used data from the WAKE-UP trial to evaluate whether MRI-guided thrombolysis is cost-effective in U.S. stroke patients with unknown time of onset. The results of the analysis will guide U.S. government treatment recommendations for stroke patients.
Research at the Deep Data Lab of the University of California, Irvine
From March to September 2019, HCHE member Jannis Kueck worked as a guest scientist at the Department of Economics of the University of California, Irvine (UCI). His research focused on the area of high-dimensional statistics in situations in which traditional approaches are not practicable. In particular, he worked on projects about causal inference using Machine Learning methods.
Based on the joint work with the Deep Data Lab and the interaction with further professors in the US, he has extended his research on transformation models in high-dimensions. In general, transformation models use a parametric transformation of the output variable to ensure statistical properties such as normal distributed error terms or homogeneity.
Furthermore, Jannis Kueck worked with Prof. Matthew Harding from the UCI’s Deep Data Lab on empirical projects. They applied his developed statistical methodology to high-dimensional data provided by the UCI.
AMNOG-Research at the Harvard University
From April to Mai 2019 HCHE-scientist Victoria Lauenroth researched at the Harvard University (Harvard Program in Therapeutic Science).
Together with Ariel Stern (Harvard Business School), Aaron Kesselheim and Ameet Sarpatwari (both Harvard Medical School), she worked on a research project that analyses the influence of regulation (of AMNOG) on the pricing of cancer medication in Germany.
The enormous pharmaceuticals prices in the USA and the lack of direct regulation currently keep patients, the media, politics and science equally concerned. Drawing lessons from the regulatory mechanisms of other countries, in particular from Europe, is therefore of great relevance.
Victoria Lauenroth on her time abroad: "In addition to research, I had the opportunity to benefit from many interesting events and lectures on the regulation of pharmaceutical markets. I also got to know a lot about healthcare in the USA and especially great cities, such as Boston and Cambridge."
AI research at the Deep Data Lab of the University of California, Irvine
Until May 2019, HCHE member Jakob Everding worked as a guest researcher at the Department of Economics der University of California, Irvine (UCI), USA.
Since the beginning of the year, he has been researching with Prof. Matthew Harding from the UCI's Deep Data Lab on factors that contribute to mental health of various risk groups and on projects on risky health behaviors. In particular, he used US data and methods from econometrics and machine learning to empirically analyze causal effects of marijuana legalization policies.
The joint research is the beginning of a long-term collaboration between the Deep Data Lab of the University of California and HCHE. Further joint projects and the exchange of scientists both in Irvine and in Hamburg will follow.